Search filters

List of works by Donald C Goff

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia

scientific article published on 01 August 2007

A 23-year-old man with schizophrenia

scientific article published on 01 June 2002

A Case of Dramatic Improvement of Severe Tardive Dyskinesia After Switch to Aripiprazole

scientific article published on January 1, 2011

A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

scientific article published on 24 February 2015

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

scientific article

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

scientific article published in June 2005

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

scientific article published in May 2005

A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia

scientific article published in December 2004

A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals

scientific article (publication date: 2011)

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

scientific article published on October 2009

A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia

scientific article published on 01 May 2005

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia

scientific article

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

scientific article published on 21 August 2008

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

scientific article

A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence

scientific article

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients

scientific article published on 21 October 2004

A successful antipsychotic combination trial. Quo Vadis?

scientific article published in October 2004

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia

scientific article published in January 2005

Aberrant frontoparietal function during recognition memory in schizophrenia: a multimodal neuroimaging investigation

scientific article

Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment

scientific article published on 3 February 2016

Abnormally persistent fMRI activation during antisaccades in schizophrenia: a neural correlate of perseveration?

scientific article

Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial

scientific article

Adverse cardiac effects associated with clozapine

scientific article

Air pollution and hippocampal atrophy in first episode schizophrenia

scientific article published on 10 March 2020

An Anterior-to-Posterior Shift in Midline Cortical Activity in Schizophrenia During Self-Reflection

scientific article published on December 8, 2010

An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia

scientific article published on January 1, 2013

Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)

scientific article

Anomalous use of context during task preparation in schizophrenia: a magnetoencephalography study

scientific article published on 4 February 2013

Anterior and posterior hippocampal volumes in schizophrenia

scientific article published in February 2005

Anterior cingulate cortex activation during cognitive interference in schizophrenia

scientific article published in April 2004

Antipsychotic Polypharmacy: Are Two Ever Better Than One?

scientific article published on 01 July 2011

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

scientific article published on 04 September 2008

Antisaccades and task switching: studies of control processes in saccadic function in normal subjects and schizophrenic patients

scientific article published on 01 April 2002

Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

scientific article

Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia

scientific article published on 03 May 2018

Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.

scientific article published on 21 February 2018

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight

scientific article published in October 2004

Becoming Adherent to Antipsychotics: A Qualitative Study of Treatment-Experienced Schizophrenia Patients

scientific article published on August 1, 2011

Biomarkers for drug development in early psychosis: Current issues and promising directions

scientific article

Bitopertin: the good news and bad news

scientific article published on 01 June 2014

Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia

scientific article published on 08 June 2012

Brexpiprazole: A New Antipsychotic Following in the Footsteps of Aripiprazole

scientific article published on 01 September 2015

Building up linguistic context in schizophrenia: evidence from self-paced reading

scientific article published on July 2006

Cannabinoids and Schizophrenia: Risks and Therapeutic Potential

scientific article

Catatonic coma with profound bradycardia

scientific article published on 01 January 2007

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

scientific article

Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.

scientific article

Clinical characteristics, cognitive functioning, and criminal histories of outpatients with schizophrenia

scientific article published on 01 December 2003

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

scientific article published in September 2005

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

scientific article

Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series

scientific article

Cognitive Therapy for Delusions in Schizophrenia: Models, Benefits, and New Approaches

Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study

scientific article

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

scientific article

Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia

scientific article

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

scientific article

D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia

scientific article published on February 23, 2012

D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity

scientific article published on 25 February 2016

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

scientific article published in July 2007

Dietary intake profile of patients with schizophrenia.

scientific article

Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone.

scientific article published in February 2010

Disrupted Working Memory Circuitry in Schizophrenia: Disentangling fMRI Markers of Core Pathology vs Other Aspects of Impaired Performance

scientific article published on 22 April 2016

Dissociable genetic contributions to error processing: a multimodal neuroimaging study

scientific article

Distinguishing familiarity-based from source-based memory performance in patients with schizophrenia

scientific article

Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?

scientific article published on January 2006

Does Early Intervention Improve the Long-Term Course of Schizophrenia?

scientific article published on 04 March 2020

Drug development in schizophrenia: are glutamatergic targets still worth aiming at?

scientific article

Dysfunction of a cortical midline network during emotional appraisals in schizophrenia

scientific article

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

scientific article published on 12 December 2011

Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants

scientific article published on 18 November 2008

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia

scientific article published on 16 January 2013

Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia

scientific article published on May 11, 2011

Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia.

scientific article published on 6 March 2007

Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia

scientific article

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

scientific article published on April 2007

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia

scientific article published on 16 November 2006

Extinction memory is impaired in schizophrenia

scientific article

Failure of Neural Responses to Safety Cues in Schizophrenia

scientific article published on September 1, 2012

Family-Directed Cognitive Adaptation Pilot: Teaching Cognitive Adaptation to Families of Individuals with Schizophrenia

scientific article published on 16 March 2016

Family-directed cognitive adaptation for schizophrenia

scientific article published in August 2009

Focus on polypharmacy in schizophrenia: does anyone truly benefit?

scientific article

Folate supplementation in schizophrenia: A possible role for MTHFR genotype

scientific article published on 21 February 2011

Folate, homocysteine, and negative symptoms in schizophrenia

scientific article

Fronto-hippocampal function during temporal context monitoring in schizophrenia

scientific article published on 3 October 2006

Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine

scientific article published in January 2005

Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia

scientific article published on June 1, 2013

Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia

scientific article published on 20 October 2011

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

scientific article

Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

scientific article published in May 2006

Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort

scientific article published in September 2007

High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia

scientific article published on 05 March 2008

High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.

scientific article

Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients.

scientific article

Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia

scientific article

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia

scientific article published in March 2010

Hippocampal and parahippocampal volumes in schizophrenia: a structural MRI study.

scientific article

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.

scientific article

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

scientific article published on 04 June 2008

Impaired hippocampal function during the detection of novel words in schizophrenia

scientific article published in April 2004

Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia

scientific article published on January 2003

Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia

scientific article published on 27 December 2005

Increased temporal and prefrontal activity in response to semantic associations in schizophrenia

scientific article published on February 2007

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

scientific article

Inflammation and schizophrenia

scientific article published on July 2007

Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

scientific article published on 29 July 2009

Initial medical work‐up of first‐episode psychosis: a conceptual review

scientific article published on February 1, 2009

Intact hemispheric specialization for spatial and shape working memory in schizophrenia.

scientific article published in October 2005

Intact suppression of increased false recognition in schizophrenia

scientific article published in September 2002

Integrating general health care in private community psychiatry practice

scientific article published on July 2007

Integrating general health care in private community psychiatry practice.

scientific article published in January 2007

Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia

scientific article

Ionotropic glutamate receptors as therapeutic targets in schizophrenia

scientific article

Is Pupillary Response a Biomarker for Effort and Defeatist Attitudes in Patients With Schizophrenia?

scientific article published on 01 October 2016

Lack of insula reactivity to aversive stimuli in schizophrenia

scientific article published on 30 November 2012

Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials

scientific article published in December 2007

Loneliness in schizophrenia and its possible correlates. An exploratory study

scientific article published on 26 September 2016

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

scientific article

MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.

scholarly article

MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study

scientific article

Maintenance treatment with long-acting injectable antipsychotics: comparing old with new

scientific article published on 01 May 2014

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

scientific article

Making sense of sentences in schizophrenia: electrophysiological evidence for abnormal interactions between semantic and syntactic processing

scientific article published on May 2006

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

scientific article

Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial

scientific article published on 11 August 2009

Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine

scientific article

Motor cortical excitability in schizophrenia

scientific article

Neural correlates of the preserved inhibition of return in schizophrenia

scientific article

Neural evidence for faster and further automatic spreading activation in schizophrenic thought disorder

scientific article published on 28 September 2007

Neurocognitive abnormalities during comprehension of real-world goal-directed behaviors in schizophrenia

scientific article

Neurocognitive mechanisms of conceptual processing in healthy adults and patients with schizophrenia

scientific article

Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia

scientific article

New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life

scientific article

No Effect of Adjunctive, Repeated-Dose Intranasal Insulin Treatment on Psychopathology and Cognition in Patients With Schizophrenia

scientific article published on April 1, 2013

No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia

scientific article published on April 1, 2011

No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia

scientific article published on February 21, 2013

Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status

scientific article

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study

scientific article

Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis

scientific article published in February 2018

Parietal memory network and default mode network in first-episode drug-naïve schizophrenia: Associations with auditory hallucination

scientific article published on 29 February 2020

Pharmacologic implications of neurobiological models of schizophrenia

scientific article

Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia

scientific article published on 13 October 2010

Polypharmacy in schizophrenia: a fuzzy concept

scientific article published on 01 September 2003

Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.

scientific article published on 21 April 2008

Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

scientific article published on 19 July 2017

Predictors of early abstinence in smokers with schizophrenia

scientific article

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

scientific article published on 30 August 2005

Prospective memory performance in patients with drug-naïve, first-episode psychosis

scientific article published on December 23, 2012

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia

scientific article

Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia

scientific article published on 24 December 2007

Reduced functional connectivity in a right-hemisphere network for volitional ocular motor control in schizophrenia

scientific article

Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia

scientific article published on 21 May 2007

Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages

scientific article

Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation?

scientific article published on 2 October 2011

Regionally localized thinning of the cerebral cortex in schizophrenia

scientific article

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia

scientific article

Reversed hemispheric asymmetry during simple visual perception in schizophrenia

scientific article published in November 2002

Review: lamotrigine may be an effective treatment for clozapine resistant schizophrenia

scientific article

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial

scientific article published on 23 February 2007

Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study

scientific article published on 22 June 2012

SU93. Targeted Treatment of a Genetic Mutation in Glycine Decarboxylase With d-Cycloserine in Psychotic Disorders.

scientific article

Schizophrenia patients show intact immediate error-related performance adjustments on an antisaccade task

scientific article published on 30 January 2006

Schizophrenic subjects show deficient inhibition but intact task switching on saccadic tasks

scientific article published on 01 May 2002

Selective emotional processing deficits to social vignettes in schizophrenia: an ERP study

scientific article

Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment

scientific article published on 20 September 2008

Sexual functioning, psychopathology and quality of life in patients with schizophrenia

scientific article published on 22 June 2007

Should CBT Target the Social Impairments Associated With Schizophrenia?

Silent demons.

scientific article published in September 2008

Slow and steady: sustained effects of lexico-semantic associations can mediate referential impairments in schizophrenia

scientific article published on June 1, 2011

Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder

scientific article published on January 1, 2010

Sustained activation of the hippocampus in response to fearful faces in schizophrenia

scientific article published in May 2005

Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia

scientific article

Task-switching in schizophrenia: active switching costs and passive carry-over effects in an antisaccade paradigm

scientific article

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

scientific article published on 24 August 2005

The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project

scientific article published on 2 October 2017

The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia

scientific article published on 5 May 2017

The association between weight change and symptom reduction in the CATIE schizophrenia trial

scientific article published on February 21, 2011

The effects of eszopiclone on sleep spindles and memory consolidation in schizophrenia: a randomized placebo-controlled trial.

scientific article published on September 2013

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls

scientific article published on 18 April 2007

The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis

scientific article published on September 2007

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia

scientific article

The inter-trial effects of stimulus and saccadic direction on prosaccades and antisaccades, in controls and schizophrenia patients

scientific article published on 27 April 2006

The misattribution of salience in delusional patients with schizophrenia

scientific article published on 15 March 2006

The potential role of lamotrigine in schizophrenia

scientific article

The relation between antisaccade errors, fixation stability and prosaccade errors in schizophrenia

scientific article published on 05 December 2007

The relationship of saccadic peak velocity to latency: evidence for a new prosaccadic abnormality in schizophrenia

article

The treatment of cognitive impairment in schizophrenia

scientific article

Training in a Clozapine Clinic for Psychiatry Residents: A Plea and Suggestions for Implementation

scientific article published on 01 January 2013

Treatment Adherence in Schizophrenia and Schizoaffective Disorder

scientific article published on April 1, 2011

Treatment of cardiac risk factors among patients with schizophrenia and diabetes

scientific article published in August 2006

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction

scientific article published on March 2004

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial

scientific article published on May 11, 2012

Varenicline treatment for smokers with schizophrenia: a case series.

scientific article published on June 2008

Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.

scientific article

What is perseverated in schizophrenia? Evidence of abnormal response plasticity in the saccadic system

scientific article published in February 2005

Why all the confusion? Experimental task explains discrepant semantic priming effects in schizophrenia under "automatic" conditions: evidence from Event-Related Potentials

scientific article published on 21 April 2009

Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

scientific article

d-Cycloserine augmentation of cognitive remediation in schizophrenia

scientific article

d-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia

scientific article published on June 30, 2011